Complaint·December 9, 2025

Two residents stated that they occasionally experience delays in receiving assistance with their daily needs but noted that the situation has been improving. The remaining three residents reported that they seldom experience any issues.A facility staff member reported that there are six caregivers and two medication technicians assigned to both the AM and PM shifts, and a total of five staff members assigned to the NOC shift. A review of the facility’s staffing schedules corroborated this information. Based on the information gathered, there is not sufficient evidence to prove that due to lack of staff the facility cannot meet the residents needs. The investigation revealed the preponderance of evidence standards have not been met; therefore, the above allegation is found to be UNSUBSTANTIATED. A finding that the complaint allegation is unsubstantiated means that although the allegation may have happened or is valid, there is not a preponderance of the evidence to prove that the alleged violation occurred. An exit interview was conducted, and a copy of this report was provided to the facility at the end of this visit. During a facility visit by the Department on 11/13/2025, it was observed that the main hallway in the memory care building also had lifted flooring and was in disrepair. Staff confirmed that these areas required repair. Additional observations were made by LPA Pascua. LPA Pascua and FDA Aguilar toured 10 resident bedrooms and common areas, including the living area, activity area, and main hallways. The majority of the 10 resident bedrooms had significant flooring lift. In addition, some ceiling tiles had been removed or were missing. Furthermore, LPA Pascua observed a large portion of the facility’s roofing that showed visible wear and tear and contained an opening. Based on the information gathered through observation and record reviewed, the preponderance of evidence was met, therefore the above allegations noted were SUBSTANTIATED. One deficiency was cited An exit interview was conducted with FDA Aguilar and a copy of the reports were provided at the end of the visit.